tiprankstipranks
Beauty Farm Medical & Health Industry, Inc. (HK:2373)
:2373
Hong Kong Market
Want to see HK:2373 full AI Analyst Report?

Beauty Farm Medical & Health Industry, Inc. (2373) AI Stock Analysis

1 Followers

Top Page

HK:2373

Beauty Farm Medical & Health Industry, Inc.

(2373)

Select Model
Select Model
Select Model
Neutral 62 (OpenAI - 5.2)
Rating:62Neutral
Price Target:
HK$18.00
▼(-31.71% Downside)
Action:Reiterated
Date:05/01/26
The score is driven primarily by solid financial performance (strong growth and improving margins) but is held back by higher leverage and some cash flow metric uncertainty. Technicals are a meaningful drag due to a sustained downtrend and negative momentum, while valuation is reasonable with a moderate P/E and a modest dividend yield.
Positive Factors
Sustained revenue expansion
The company recorded a marked step-up in revenue in 2025 versus prior years. Durable top-line growth over multiple years supports scaling of care operations, strengthens pricing leverage, and provides a larger base to convert incremental revenue into long‑term cash generation and reinvestment.
Negative Factors
Sharply higher leverage
Leverage jumped materially in 2025, reducing financial flexibility. For a care-facilities operator, higher debt raises interest and refinancing risk, limits ability to invest opportunistically, and increases vulnerability to slower cash conversion or reimbursement shifts, weighing on durable stability.
Read all positive and negative factors
Positive Factors
Negative Factors
Sustained revenue expansion
The company recorded a marked step-up in revenue in 2025 versus prior years. Durable top-line growth over multiple years supports scaling of care operations, strengthens pricing leverage, and provides a larger base to convert incremental revenue into long‑term cash generation and reinvestment.
Read all positive factors

Beauty Farm Medical & Health Industry, Inc. (2373) vs. iShares MSCI Hong Kong ETF (EWH)

Beauty Farm Medical & Health Industry, Inc. Business Overview & Revenue Model

Company Description
Beauty Farm Medical and Health Industry Inc., established in 1993 and based in Shanghai, People's Republic of China, delivers comprehensive beauty and health management services across China. Its diverse offerings encompass traditional beauty trea...
How the Company Makes Money
null...

Beauty Farm Medical & Health Industry, Inc. Financial Statement Overview

Summary
Strong revenue expansion (notably in 2025) and improving profitability (net margin up from 8.9% to 10.6%) support a solid fundamental profile. Offsetting this, leverage rose sharply in 2025 (debt-to-equity to 1.27) and cash flow coverage metrics are unclear despite positive cash generation, increasing risk and reducing confidence in consistency.
Income Statement
78
Positive
Balance Sheet
56
Neutral
Cash Flow
62
Positive
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue3.00B2.57B2.15B1.64B1.78B
Gross Profit1.47B1.19B977.10M717.84M833.79M
EBITDA603.50M427.49M644.82M452.43M554.51M
Net Income317.56M228.46M215.66M103.11M193.47M
Balance Sheet
Total Assets5.05B4.28B3.30B2.50B2.48B
Cash, Cash Equivalents and Short-Term Investments2.57B1.83B1.57B910.63M1.08B
Total Debt1.29B730.59M563.12M525.50M515.46M
Total Liabilities3.98B3.30B2.47B2.29B2.21B
Stockholders Equity1.02B944.64M801.90M188.75M257.36M
Cash Flow
Free Cash Flow932.01M682.44M466.27M241.21M536.76M
Operating Cash Flow999.09M796.63M625.51M382.00M669.93M
Investing Cash Flow-396.42M-340.85M-711.18M53.63M-385.35M
Financing Cash Flow51.79M-223.36M133.74M-432.82M-271.06M

Beauty Farm Medical & Health Industry, Inc. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price26.36
Price Trends
50DMA
19.34
Negative
100DMA
21.45
Negative
200DMA
25.96
Negative
Market Momentum
MACD
-0.61
Positive
RSI
35.24
Neutral
STOCH
19.99
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2373, the sentiment is Negative. The current price of 26.36 is above the 20-day moving average (MA) of 18.03, above the 50-day MA of 19.34, and above the 200-day MA of 25.96, indicating a bearish trend. The MACD of -0.61 indicates Positive momentum. The RSI at 35.24 is Neutral, neither overbought nor oversold. The STOCH value of 19.99 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:2373.

Beauty Farm Medical & Health Industry, Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
67
Neutral
HK$368.44M11.254.28%7.10%-2.78%-24.77%
62
Neutral
HK$4.31B10.5733.37%1.97%16.70%38.98%
60
Neutral
HK$1.03B31.681.27%
54
Neutral
HK$1.42B103.330.48%0.49%-2.63%
52
Neutral
HK$5.40B109.300.60%-9.81%-72.56%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
49
Neutral
HK$62.39M30.711.67%-4.86%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:2373
Beauty Farm Medical & Health Industry, Inc.
16.85
-11.49
-40.54%
HK:2135
Raily Aesthetic Medicine International Holdings Limited
0.11
-0.02
-13.39%
HK:3886
Town Health International Medical Group Ltd.
0.22
-0.02
-9.58%
HK:6078
Hygeia Healthcare Holdings Co., Ltd.
8.84
-6.38
-41.92%
HK:6639
Arrail Group Ltd.
1.83
-0.29
-13.73%
HK:0722
UMP Healthcare Holdings Limited
0.46
0.02
3.84%

Beauty Farm Medical & Health Industry, Inc. Corporate Events

Beauty Farm Updates Timetable for 2025 Final Dividend of HKD 0.72 Per Share
May 28, 2026
Beauty Farm Medical and Health Industry Inc. has announced an updated schedule for its final cash dividend for the year ended December 31, 2025, declaring a payout of HKD 0.72 per share subject to shareholder approval on June 26, 2026. The company...
Beauty Farm Sets 2026 AGM to Approve Dividend, Board Changes and Capital Mandates
May 28, 2026
Beauty Farm Medical and Health Industry Inc. has called its annual general meeting for June 26, 2026 in Hong Kong, where shareholders will review the audited financial statements for the year ended December 31, 2025 and vote on key corporate matte...
Beauty Farm Proposes Governance Upgrade With New Memorandum and Articles
May 26, 2026
Beauty Farm Medical Health Industry Inc. has proposed amendments to its existing constitutional documents, aiming to update its memorandum and articles of association to align with the latest regulatory requirements in Hong Kong. The revisions ar...
Beauty Farm Boosts Profit and Dividend on Strong 2025 Growth in Premium Beauty Services
Mar 27, 2026
Beauty Farm Medical and Health Industry Inc., a major Chinese beauty and health service chain, focuses on one-stop beauty and wellness offerings for women in high-tier cities, leveraging a dual beauty plus dual wellness model. The company position...
Beauty Farm Medical and Health Industry Declares HKD 0.72 Final Dividend for 2025
Mar 27, 2026
Beauty Farm Medical and Health Industry Inc. has declared a final ordinary cash dividend of HKD 0.72 per share for the financial year ended 31 December 2025, subject to shareholder approval at a meeting scheduled for 26 June 2026. Key dates such a...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: May 01, 2026